Search Results

A California life sciences company named Biomedican is drawing significant attention for the rapid progress it’s made in patented, low-cost methods of biosynthesizing rare cannabinoids.

United Kingdom-based GW Pharmaceuticals posted higher revenue in the quarter ended Sept. 30, largely driven by U.S. sales of its cannabidiol medicine Epidiolex.

Back in the early days of Canada’s regulated adult-use cannabis industry, some of the country’s biggest publicly traded marijuana producers discovered that investors rewarded international ambitions.

Research published in Cannabis and Cannabinoid Research suggests the way CBD extracts are stored could have an effect on how much THC the final product contains.

England’s medical cannabis market has barely gotten off the ground since launching about 19 months ago, with a two-tier system in which few patients access products through legal channels while most resort to illicit suppliers.

Australia has published a framework for new CBD regulations as it considers relaxing its narcotics scheduling of cannabidiol to make it available over the counter in limited doses.